Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD

Published:2020-05 Issue:5 Volume:157 Page:1117-1129
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Chang Ting-Yu,Chien Jung-Yien,Wu Chung-Hsuen,Dong Yaa-Hui,Lin Fang-Ju

Funder

Taiwan’s Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference33 articles.

1. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study;Murray;Lancet,1997

2. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide;Wedzicha;Am J Respir Crit Care Med,2008

3. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study;Wang;Int J Chron Obstruct Pulmon Dis,2016

4. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study;Kern;Respir Res,2015

5. Inhaled corticosteroids in COPD and the risk of serious pneumonia;Suissa;Thorax,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled corticosteroids in severe COPD patients with cardiovascular diseases. Authors’ reply;European Journal of Internal Medicine;2024-08

2. Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β ₂ -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis;Expert Review of Clinical Pharmacology;2024-01-26

3. Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial;BMC Complementary Medicine and Therapies;2024-01-08

4. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS;Pragmatic and Observational Research;2024-01

5. Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety;COPD: Journal of Chronic Obstructive Pulmonary Disease;2022-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3